NIH rare diseases coordinator
HHS Assistant Secretary for Health Mason announced at May 3 meeting on rare diseases that Stephen Groft, formerly with FDA's Office of Orphan Products, is being appointed coordinator for rare disease activities at the National Institutes of Health. Groft will work with a network of about 20 staff members who have been designated as focal points for rare disease research within NIH, Mason said. Groft also will work with FDA on developing implementation plans for recommendations made by the National Commission on Orphan Diseases.
You may also be interested in...
Cosmetics Europe Talks Microplastic: ECHA Frustrations, ‘Value Judgments’ And International Trade Uncertainty
The European Chemicals Agency's microplastic restriction proposal received committee backing in 2020 without changes sought by the cosmetics industry, which faces €15bn in projected costs and scarce alternatives at present. It may come down to EU Member States to decide whether the ECHA restriction proposal is proportionate in balancing environmental goals and socio-economic impacts.
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.